Skip to main content

Table 4 Questions indicating satisfaction with pre-test counseling

From: Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing

 

Options

Intervention group, n = 105

Control group, n = 91

P-value

Clarity of discussed information regarding the DNA test, n (%)

- (very) clear

98 (93.3)

89 (97.8)

0.156

- unsure/not clear

7 (6.7)

2 (2.2)

Received written information after discussing DNA test, n (%)

- yes

81 (77.1)

not askeda

N/A

- no

22 (21.0)

- missing

2 (1.9)

 Clarity of received written information after discussing the DNA test, n (%)

- (very) clear

75 (92.6)

88 (96.7)

0.239

- unsure/not clear

6 (7.4)

3 (3.3)

There was enough time to weigh the advantages and disadvantages of a DNA test, n (%)

- yes

80 (76.2)

86 (94.5)

0.002*

- no

4 (3.8)

1 (1.1)

- don’t know

21 (20.0)

4 (4.4)

Feeling of having a choice whether or not to perform a DNA test, n (%)

- yes

97 (92.4)

79 (86.8)

0.082

- no

3 (2.9)

9 (9.9)

- don’t know

5 (4.8)

2 (2.2)

- missing

0

1 (1.1)

Satisfaction with being offered a DNA test, n (%)

- (very) satisfied

95 (90.5)

88 (96.7)

0.134

- unsure/not satisfied

9 (8.6)

3 (3.3)

- missing

1 (1)

0

Preferred moment to be offered a DNA test, n (%)

- directly after diagnosis

57 (54.3)

45 (49.5)

0.236

- during treatment

3 (2.9)

2 (2.2)

- after completion of treatment

30 (28.6)

38 (41.8)

- in case of recurrence

4 (3.8)

4 (4.4)

- other

8 (7.6)

2 (2.2)

- missing

3 (2.9)

0

  1. N/A Not applicable
  2. *p ≤ 0.05
  3. a For the control group it was assumed that all patients did receive written information after discussing the DNA test and therefore this was not asked in the questionnaire